Surface Logix
About:
Surface Logix is a drug development company using biophysical chemistry to create new small molecule drugs.
Website: http://www.surfacelogix.com
Top Investors: ARCH Venture Partners, Intel Capital, Venrock, Silicon Valley Bank, MPM Capital
Description:
Surface Logix is a drug development company which uses its expertise in biophysical chemistry to create new small molecule drugs with significantly improved pharmacokinetic (PK) and pharmacodynamic (PD) properties compared with class leaders.
Total Funding Amount:
$101M
Headquarters Location:
Brighton, Massachusetts, United States
Founded Date:
1999-01-01
Contact Email:
info(AT)surfacelogix.com
Founders:
Carmichael Roberts
Number of Employees:
1-10
Last Funding Date:
2010-07-16
IPO Status:
Private
Industries:
© 2025 bioDAO.ai